Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck
Pharma
Merck-Gilead first-of-its-kind combo pill scores in 2 HIV trials
A combo pill from Merck and Gilead has succeeded in two phase 3 trials and is set up to become the first oral HIV treatment that can be taken weekly.
Kevin Dunleavy
Jun 9, 2026 11:20am
Lilly, Boehringer slash investment plans in Germany
Jun 3, 2026 3:10pm
AZ gains on Merck with 2nd bladder cancer nod for Imfinzi
May 28, 2026 4:39pm
In endometrial cancer, Merck and Kelun score with sac-TMT
May 18, 2026 11:21am
Merck reports mixed results in Q1 for Winrevair, Ohtuvayre
Apr 30, 2026 11:40am
Merck bats for heart disease awareness
Apr 30, 2026 9:30am
